GSK names chief medical officer
Executive Summary
GlaxoSmithKline recruits Pfizer Licensing, Worldwide Business Development VP Ellen Strahlman as chief medical officer. An ophthalmologist, Strahlman also previously worked as chief medical officer and global head of R&D for Bausch & Lomb and was CEO of ViroGen, a biotech firm. Announcing the appointment, GSK R&D Chairman Moncef Slaoui cites Strahlman's medical expertise and business development experience as key attributes. Her selection points to GSK's emphasis on seeking external R&D candidates to continue its licensing push